These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8067036)

  • 1. [The insulin therapy of patients with terminal chronic kidney failure].
    Tychka IB; Petrykiv AV
    Lik Sprava; 1994 Jan; (1):96-9. PubMed ID: 8067036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of insulin therapy on erythrocyte insulin receptor activity in patients with terminal kidney failure].
    Tychka IB; Zahraĭ LB
    Lik Sprava; 1998; (7):80-2. PubMed ID: 10050466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Difficult therapy in patients with renal failure. What protects, what damages the kidneys?].
    Stiefelhagen P
    MMW Fortschr Med; 2005 Apr; 147(16):4-6. PubMed ID: 16392389
    [No Abstract]   [Full Text] [Related]  

  • 4. Decreased erythrocyte insulin receptor binding in diabetic man with chronic renal failure.
    Gambhir KK; Nerurkar SG; Cruz IA; Hosten AO
    Horm Metab Res; 1980 Aug; 12(8):414-5. PubMed ID: 6997168
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmocodynamics of lividomycin in renal failure.
    Fillastre JP; Humbert G; Daufresne MF; Dubois D; Leroy A
    Proc Eur Dial Transplant Assoc; 1973; 10(0):547-50. PubMed ID: 4802558
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nutritional problems in intermittent continuous hemodialysis of chronic kidney patients].
    Kessel M; Nagel A
    Med Klin; 1970 Feb; 65(8):335-41. PubMed ID: 5519229
    [No Abstract]   [Full Text] [Related]  

  • 7. [Advantages of insulin Lispro (short-acting) in terminal kidney failure].
    Jehle PM; Aisenpreis U; Bundschu D; Keller F
    Fortschr Med; 1999 Apr; 117(11):41-2. PubMed ID: 10339922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of recombinant human erythropoietin on the rate of Na+,H+-exchange in erythrocytes of patients with chronic kidney insufficiency treated by hemodialysis].
    Kubatiev AA; Rud'ko IA; Ermolenko VM
    Biull Eksp Biol Med; 1997 Dec; 124(12):613-5. PubMed ID: 9483309
    [No Abstract]   [Full Text] [Related]  

  • 9. Intraperitoneal administration of insulin during peritoneal dialysis of diabetic patients with terminal renal failure.
    Andersen KE; Petersen PH
    Proc Eur Dial Transplant Assoc; 1981; 18():206-11. PubMed ID: 7036148
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of dialysis membranes on lipid peroxidation in erythrocytes of patients with terminal renal failure].
    Kubatiev AA; Rud'ko IA; Balashova TS; Ermolenko VM
    Biull Eksp Biol Med; 1994 Nov; 118(11):460-2. PubMed ID: 7888639
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of anabolic steroid administration to patients with chronic renal failure including cases on long-term dialysis treatment].
    Niijima H; Omori H; Ishi M
    Horumon To Rinsho; 1972 Feb; 20(2):157-64. PubMed ID: 5063415
    [No Abstract]   [Full Text] [Related]  

  • 12. Pre-dialysis insulin: a new concept to treat an old problem.
    Marchant K
    Br J Nurs; 2009 Sep 24-Oct 7; 18(17):1044-9. PubMed ID: 19798002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen-induced increase in red-cell 2,3-diphosphoglycerate.
    Parker JP; Beirne GJ; Desai JN; Raich PC; Shahidi NT
    N Engl J Med; 1972 Aug; 287(8):381-3. PubMed ID: 5043522
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of hemodialysis on hormone status of terminal kidney failured patients].
    Bindeballe W; Leybold K; Niedermayer W; Schaper H; Schemmel K; Weisbecker L
    Verh Dtsch Ges Inn Med; 1973; 79():1249-52. PubMed ID: 4790149
    [No Abstract]   [Full Text] [Related]  

  • 15. [Possibilities of insulin administration in diabetics with kidney failure during CAPD treatment].
    Thomae U; Kuhlmann H
    Med Welt; 1980 Aug; 31(34):1202-4. PubMed ID: 7001164
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glyceraldehydephosphate dehydrogenase activity in the erythrocytes of patients with terminal chronic renal failure treated with repeated dialysis].
    Kopczyński Z; Chmiel J; Dryl T; Czarnecki R
    Pol Tyg Lek; 1982 Oct; 37(39):1157-9. PubMed ID: 7163058
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on glucose intolerance in chronic renal failure--estimation of insulin sensitivity before and after introduction of hemodialysis].
    Oshida Y; Sato Y; Shiraishi S; Sakamoto N; Ota K
    Nihon Jinzo Gakkai Shi; 1986 Feb; 28(2):169-75. PubMed ID: 3525915
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin-glucose infusion given before hemodialysis increases IGF-I in type 2 diabetes patients with chronic kidney disease.
    Lindgren BF; Jacobson SH; Brismar K
    Growth Horm IGF Res; 2010 Dec; 20(6):422-6. PubMed ID: 21051252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of amrinone in terminal dialysis-dependent renal failure].
    Stengele E; Trenk D
    Med Klin (Munich); 1992 May; 87(5):278-80. PubMed ID: 1614376
    [No Abstract]   [Full Text] [Related]  

  • 20. [Analysis of 30 chronic renal failure patients treated with oral dialysis and Chinese drugs].
    Jiang YS; Lou JA; Zhan JG
    Zhong Xi Yi Jie He Za Zhi; 1988 Jul; 8(7):398-9, 387. PubMed ID: 3208404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.